Stacy L. Chin explains that startups can get NIH R01 and R21 grants, not just academic labs. She covers ARPA-H THRIVE for rare genetic diseases, the Alzheimer's and Cancer Moonshots, and Department of Defense funding for cell therapy and regenerative medicine.
Here's a myth I need to bust. You don't have to be an academic to also go for an R01 or R21 because NIH is also funding startups through these vehicles, and they're very interested if your science is strong and your roadmap is translational. And here's some other examples of funding vehicles. ARPA-H's THRIVE program is developing one-shot cures for rare genetic diseases. NIH's Alzheimer's and Cancer Moonshot programs are growing rapidly despite even tighter budgets this coming year. And DOD is interested in funding cell therapies. Regenerative medicine, and trauma solutions for dual-use applications.
Applying for NIH SBIR in Jan 5, 2027? You Should Be Starting NOW. Here's why...
How to Get Invited to Apply for $305K in NSF SBIR Funding || Step-by-Step Guide
